Histology-tailored multidisciplinary management of primary retroperitoneal sarcomas
Until recently, the recommendation for primary retroperitoneal sarcomas (RPS) was to perform a complete en-bloc gross excision, (neo) adjuvant treatments being options which were not validated by randomized studies, with a large discrepancy of use between centers. The heterogeneity of RPS, with thei...
Gespeichert in:
| Veröffentlicht in: | European journal of surgical oncology 2023-06, Vol.49 (6), p.1061-1067 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1067 |
|---|---|
| container_issue | 6 |
| container_start_page | 1061 |
| container_title | European journal of surgical oncology |
| container_volume | 49 |
| creator | Bonvalot, S. Roland, C. Raut, C. Le Péchoux, C. Tzanis, D. Frezza, A.M. Gronchi, A. |
| description | Until recently, the recommendation for primary retroperitoneal sarcomas (RPS) was to perform a complete en-bloc gross excision, (neo) adjuvant treatments being options which were not validated by randomized studies, with a large discrepancy of use between centers. The heterogeneity of RPS, with their different biological behaviour, renders a homogenous therapeutic and surgical approach probably inappropriate. Recent studies, both surgical and dedicated to adjuvant treatments, allow refining these recommendations. This review summarizes recent advances and directions. |
| doi_str_mv | 10.1016/j.ejso.2022.05.010 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2668221749</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0748798322004358</els_id><sourcerecordid>2668221749</sourcerecordid><originalsourceid>FETCH-LOGICAL-c400t-9c6f5a4f4d2e83223ee684e6d67bf2102cee82a29b56084108e943b6098e15d23</originalsourceid><addsrcrecordid>eNp9kMFq3DAQhkVpaDabvkAPxcde7IxGlixBL2FJm8BCDknOQmuPgxbb2krawL59vOw2x5wGhu__mfkY-8Gh4sDVzbaibQoVAmIFsgIOX9iCS4Elctl8ZQtoal02RotLdpXSFgCMaMw3dimkNIYLvWBP9z7lMITXQ5mdH0Kkrhj3Q_adT63fDX5y8VCMbnKvNNKUi9AXu-jH4zZSjmFH0ecwkRuK5GIbRpeu2UXvhkTfz3PJXv7cPa_uy_Xj34fV7bpsa4Bcmlb10tV93SFpgSiIlK5JdarZ9MgBWyKNDs1GKtA1B02mFhsFRhOXHYol-3Xq3cXwb08p23E-mobBTRT2yaJSGpE3tZlRPKFtDClF6u35CcvBHmXarT3KtEeZFqSdZc6hn-f-_Wak7iPy394M_D4BNH_55ina2RlNLXU-UpttF_xn_e-GX4c6</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2668221749</pqid></control><display><type>article</type><title>Histology-tailored multidisciplinary management of primary retroperitoneal sarcomas</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Bonvalot, S. ; Roland, C. ; Raut, C. ; Le Péchoux, C. ; Tzanis, D. ; Frezza, A.M. ; Gronchi, A.</creator><creatorcontrib>Bonvalot, S. ; Roland, C. ; Raut, C. ; Le Péchoux, C. ; Tzanis, D. ; Frezza, A.M. ; Gronchi, A.</creatorcontrib><description>Until recently, the recommendation for primary retroperitoneal sarcomas (RPS) was to perform a complete en-bloc gross excision, (neo) adjuvant treatments being options which were not validated by randomized studies, with a large discrepancy of use between centers. The heterogeneity of RPS, with their different biological behaviour, renders a homogenous therapeutic and surgical approach probably inappropriate. Recent studies, both surgical and dedicated to adjuvant treatments, allow refining these recommendations. This review summarizes recent advances and directions.</description><identifier>ISSN: 0748-7983</identifier><identifier>EISSN: 1532-2157</identifier><identifier>DOI: 10.1016/j.ejso.2022.05.010</identifier><identifier>PMID: 35599138</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Chemotherapy ; Diagnosis ; Humans ; leiomyosarcoma ; Liposarcoma ; Neoplasm Recurrence, Local - therapy ; Radiotherapy ; Retroperitoneal Neoplasms - surgery ; Retroperitoneal sarcoma ; Retroperitoneal tumour ; Retrospective Studies ; Sarcoma - surgery ; Solitary fibrous Tumor ; Surgery ; Survival Rate</subject><ispartof>European journal of surgical oncology, 2023-06, Vol.49 (6), p.1061-1067</ispartof><rights>2022 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology</rights><rights>Copyright © 2022 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c400t-9c6f5a4f4d2e83223ee684e6d67bf2102cee82a29b56084108e943b6098e15d23</citedby><cites>FETCH-LOGICAL-c400t-9c6f5a4f4d2e83223ee684e6d67bf2102cee82a29b56084108e943b6098e15d23</cites><orcidid>0000-0001-9726-9732 ; 0000-0001-7297-3221 ; 0000-0003-3400-0087 ; 0000-0002-4703-3534</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ejso.2022.05.010$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35599138$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bonvalot, S.</creatorcontrib><creatorcontrib>Roland, C.</creatorcontrib><creatorcontrib>Raut, C.</creatorcontrib><creatorcontrib>Le Péchoux, C.</creatorcontrib><creatorcontrib>Tzanis, D.</creatorcontrib><creatorcontrib>Frezza, A.M.</creatorcontrib><creatorcontrib>Gronchi, A.</creatorcontrib><title>Histology-tailored multidisciplinary management of primary retroperitoneal sarcomas</title><title>European journal of surgical oncology</title><addtitle>Eur J Surg Oncol</addtitle><description>Until recently, the recommendation for primary retroperitoneal sarcomas (RPS) was to perform a complete en-bloc gross excision, (neo) adjuvant treatments being options which were not validated by randomized studies, with a large discrepancy of use between centers. The heterogeneity of RPS, with their different biological behaviour, renders a homogenous therapeutic and surgical approach probably inappropriate. Recent studies, both surgical and dedicated to adjuvant treatments, allow refining these recommendations. This review summarizes recent advances and directions.</description><subject>Chemotherapy</subject><subject>Diagnosis</subject><subject>Humans</subject><subject>leiomyosarcoma</subject><subject>Liposarcoma</subject><subject>Neoplasm Recurrence, Local - therapy</subject><subject>Radiotherapy</subject><subject>Retroperitoneal Neoplasms - surgery</subject><subject>Retroperitoneal sarcoma</subject><subject>Retroperitoneal tumour</subject><subject>Retrospective Studies</subject><subject>Sarcoma - surgery</subject><subject>Solitary fibrous Tumor</subject><subject>Surgery</subject><subject>Survival Rate</subject><issn>0748-7983</issn><issn>1532-2157</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMFq3DAQhkVpaDabvkAPxcde7IxGlixBL2FJm8BCDknOQmuPgxbb2krawL59vOw2x5wGhu__mfkY-8Gh4sDVzbaibQoVAmIFsgIOX9iCS4Elctl8ZQtoal02RotLdpXSFgCMaMw3dimkNIYLvWBP9z7lMITXQ5mdH0Kkrhj3Q_adT63fDX5y8VCMbnKvNNKUi9AXu-jH4zZSjmFH0ecwkRuK5GIbRpeu2UXvhkTfz3PJXv7cPa_uy_Xj34fV7bpsa4Bcmlb10tV93SFpgSiIlK5JdarZ9MgBWyKNDs1GKtA1B02mFhsFRhOXHYol-3Xq3cXwb08p23E-mobBTRT2yaJSGpE3tZlRPKFtDClF6u35CcvBHmXarT3KtEeZFqSdZc6hn-f-_Wak7iPy394M_D4BNH_55ina2RlNLXU-UpttF_xn_e-GX4c6</recordid><startdate>202306</startdate><enddate>202306</enddate><creator>Bonvalot, S.</creator><creator>Roland, C.</creator><creator>Raut, C.</creator><creator>Le Péchoux, C.</creator><creator>Tzanis, D.</creator><creator>Frezza, A.M.</creator><creator>Gronchi, A.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-9726-9732</orcidid><orcidid>https://orcid.org/0000-0001-7297-3221</orcidid><orcidid>https://orcid.org/0000-0003-3400-0087</orcidid><orcidid>https://orcid.org/0000-0002-4703-3534</orcidid></search><sort><creationdate>202306</creationdate><title>Histology-tailored multidisciplinary management of primary retroperitoneal sarcomas</title><author>Bonvalot, S. ; Roland, C. ; Raut, C. ; Le Péchoux, C. ; Tzanis, D. ; Frezza, A.M. ; Gronchi, A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c400t-9c6f5a4f4d2e83223ee684e6d67bf2102cee82a29b56084108e943b6098e15d23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Chemotherapy</topic><topic>Diagnosis</topic><topic>Humans</topic><topic>leiomyosarcoma</topic><topic>Liposarcoma</topic><topic>Neoplasm Recurrence, Local - therapy</topic><topic>Radiotherapy</topic><topic>Retroperitoneal Neoplasms - surgery</topic><topic>Retroperitoneal sarcoma</topic><topic>Retroperitoneal tumour</topic><topic>Retrospective Studies</topic><topic>Sarcoma - surgery</topic><topic>Solitary fibrous Tumor</topic><topic>Surgery</topic><topic>Survival Rate</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bonvalot, S.</creatorcontrib><creatorcontrib>Roland, C.</creatorcontrib><creatorcontrib>Raut, C.</creatorcontrib><creatorcontrib>Le Péchoux, C.</creatorcontrib><creatorcontrib>Tzanis, D.</creatorcontrib><creatorcontrib>Frezza, A.M.</creatorcontrib><creatorcontrib>Gronchi, A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of surgical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bonvalot, S.</au><au>Roland, C.</au><au>Raut, C.</au><au>Le Péchoux, C.</au><au>Tzanis, D.</au><au>Frezza, A.M.</au><au>Gronchi, A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Histology-tailored multidisciplinary management of primary retroperitoneal sarcomas</atitle><jtitle>European journal of surgical oncology</jtitle><addtitle>Eur J Surg Oncol</addtitle><date>2023-06</date><risdate>2023</risdate><volume>49</volume><issue>6</issue><spage>1061</spage><epage>1067</epage><pages>1061-1067</pages><issn>0748-7983</issn><eissn>1532-2157</eissn><abstract>Until recently, the recommendation for primary retroperitoneal sarcomas (RPS) was to perform a complete en-bloc gross excision, (neo) adjuvant treatments being options which were not validated by randomized studies, with a large discrepancy of use between centers. The heterogeneity of RPS, with their different biological behaviour, renders a homogenous therapeutic and surgical approach probably inappropriate. Recent studies, both surgical and dedicated to adjuvant treatments, allow refining these recommendations. This review summarizes recent advances and directions.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>35599138</pmid><doi>10.1016/j.ejso.2022.05.010</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0001-9726-9732</orcidid><orcidid>https://orcid.org/0000-0001-7297-3221</orcidid><orcidid>https://orcid.org/0000-0003-3400-0087</orcidid><orcidid>https://orcid.org/0000-0002-4703-3534</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0748-7983 |
| ispartof | European journal of surgical oncology, 2023-06, Vol.49 (6), p.1061-1067 |
| issn | 0748-7983 1532-2157 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2668221749 |
| source | MEDLINE; Access via ScienceDirect (Elsevier) |
| subjects | Chemotherapy Diagnosis Humans leiomyosarcoma Liposarcoma Neoplasm Recurrence, Local - therapy Radiotherapy Retroperitoneal Neoplasms - surgery Retroperitoneal sarcoma Retroperitoneal tumour Retrospective Studies Sarcoma - surgery Solitary fibrous Tumor Surgery Survival Rate |
| title | Histology-tailored multidisciplinary management of primary retroperitoneal sarcomas |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T00%3A26%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Histology-tailored%20multidisciplinary%20management%20of%20primary%20retroperitoneal%20sarcomas&rft.jtitle=European%20journal%20of%20surgical%20oncology&rft.au=Bonvalot,%20S.&rft.date=2023-06&rft.volume=49&rft.issue=6&rft.spage=1061&rft.epage=1067&rft.pages=1061-1067&rft.issn=0748-7983&rft.eissn=1532-2157&rft_id=info:doi/10.1016/j.ejso.2022.05.010&rft_dat=%3Cproquest_cross%3E2668221749%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2668221749&rft_id=info:pmid/35599138&rft_els_id=S0748798322004358&rfr_iscdi=true |